Claudine Bruck - 07 Apr 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Henry Hagopian, III, Attorney-in-Fact for Claudine Bruck
Issuer symbol
ANVS
Transactions as of
07 Apr 2023
Net transactions value
+$6,305
Form type
4
Filing time
11 Apr 2023, 21:11:11 UTC
Previous filing
20 Jan 2023
Next filing
03 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Award $6,305 +500 +8.2% $12.61 6,567 07 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.